Joseph Bertolini, Director, R & D, Albumin and Immunoglobulin, CSL Behring, Melbourne, Australia.
Dr Joseph Bertolini is an R&D Director at CSL Behring (Australia) and has been closely involved in the technical development and improvement of the immunoglobulin and albumin products currently manufactured at CSL Behring (Australia).
Exploring new manufacturing technologies with the aim of improving through-put, yield, process robustness and ensuring compliance with developing quality regulations are an important focus. He is also interested in establishing and adopting new techniques for studying the physiochemical and biological properties of proteins as a means of establishing product comparability and ensuring product function and safety. Identifying new product opportunities for plasma derived proteins are another of his interests. He maintains an active collaboration with external institutes as a means of accessing new technological and conceptual advances. He is interested in advancing the field of bioprocessing and contributes to the activities of a number of national and international conference and industry organisations. He recently contributed chapters to and was chief editor of a book titled “Production of Plasma Proteins for Therapeutic Use’’.